Samsung to spend $360 billion on microchips, biotech over five years

Samsung promised in a statement to create 80,000 jobs through 2026, mostly in semiconductors and biopharmaceuticals.

microchip
Photo: Bloomberg
Shinhye Kang | Bloomberg
3 min read Last Updated : May 25 2022 | 3:16 AM IST
The Samsung group plans to raise spending by more than 30 per cent to 450 trillion won (about $360 billion) over the half-decade to 2026 to shore up businesses from chips to drugs as South Korea’s conglomerates grapple with growing economic and supply shocks.

The conglomerate -- whose units from Samsung Electronics Co to Samsung Biologics Co dominate Korea’s economy -- promised in a statement to create 80,000 jobs through 2026, mostly in semiconductors and biopharmaceuticals.

Samsung, run by the scion of one of Korea’s oldest and wealthiest families, is one of a handful of so-called chaebol that are outlining investment plans as the country’s new president takes office. President Yoon Suk Yeol, who began his five-year term May 10, has been a vocal supporter of the conglomerates and has made them a key pillar in his economic growth plans. 

The group is focusing particular attention to Samsung Electronics, the crown jewel of a multibillion-dollar sprawling empire that spans shipbuilding, technology, health care and finance. The world’s largest maker of smartphones, displays, memory chips and consumer appliances unveiled plans last year to invest $151 billion through 2030 to delve deeper into advanced chipmaking. Much of that will go toward its semiconductor division, which is expanding rapidly in an effort to compete with Intel Corp. and Taiwan Semiconductor Manufacturing Co. in making chips for global names such as Nvidia Corp. and Qualcomm Inc.

Samsung Group’s latest investment blueprint, which overlaps with public pledges made in 2021, comes about a year after family scion Jay Y. Lee walked out of jail. The conglomerate’s leader, who was serving a sentence on graft charges, was paroled just months ahead of presidential election earlier this year. 

Along with the heads of other prominent chaebol including the Hyundai and SK groups, Samsung is expected to shoulder part of the responsibility for driving growth in a country dealing with rising inflation and supply chain disruptions due to the pandemic and war in Ukraine. Samsung Electronics and SK Hynix Inc. had pledged more than 510 trillion won of investment in semiconductor research and production in the years to 2030 under a national blueprint devised by the previous president’s administration.

In a statement, the group said about 360 trillion won will be spent domestically while the rest will be invested overseas. Samsung Electronics is building an advanced $17 billion US chip plant in Texas, a win for the Biden administration as it prioritizes supply chain security and greater semiconductor capacity on American soil. Last week, Joe Biden stopped by Samsung’s most advanced chipmaking facility on his first trip to Asia as US president, hailing joint efforts on safeguarding supply chain security.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :SamsungsemiconductorBiotechnologySouth KoreaSamsung Electronics

Next Story